Multimorbidity patterns shape mobility disability prevention in frail older adults

For millions of older adults living with multiple chronic diseases, the loss of the ability to walk even a few hundred meters marks the beginning of a cascade that ends in dependence, institutionalization and early death. A new analysis published in Nature Aging suggests that whether physical activity can prevent that cascade depends not simply on how many diseases a person has, but on which diseases cluster together in their body. Drawing on data from the landmark SPRINTT trial, researchers led by Davide Vetrano and colleagues show that distinct patterns of multimorbidity — the co-occurrence of several chronic conditions in the same individual — shape how frail older adults respond to a structured physical activity program aimed at preserving mobility. The findings carry substantial implications for the clinical management of the fastest-growing segment of the population: people over seventy who carry two, three or more diagnoses at once.

The SPRINTT trial, funded by the European Union’s Horizon 2020 program, was one of the largest randomized controlled trials ever conducted in community-dwelling frail older Europeans. It enrolled more than 1,500 men and women aged seventy and above across multiple European countries, all of whom met criteria for physical frailty and sarcopenia — a combination characterized by slowness, weakness, low physical activity and reduced muscle mass. Participants were randomized to either a moderate-intensity, multicomponent physical activity program, centered on walking and adapted to individual capacity, or to a control group receiving structured health education. The primary goal was to prevent major mobility disability, defined as the inability to walk 400 meters, a threshold with proven clinical relevance because it captures the capacity to function independently in everyday life. Earlier reports from the trial indicated that the intervention produced statistically significant but modest benefits, leaving open the crucial question of whether particular subgroups of patients benefited more than others.

The new study addresses that question through the lens of multimorbidity patterns rather than simple disease counts. Most previous analyses treated multimorbidity as a number — two diseases, three diseases, four or more — or as a crude index of cumulative burden. But clinicians have long observed that a patient with diabetes, peripheral vascular disease and osteoarthritis is not clinically equivalent to a patient with chronic obstructive pulmonary disease, heart failure and depression, even if both carry the same number of diagnoses. The researchers therefore applied statistical clustering techniques to the participants’ disease profiles, identifying groups of conditions that tended to occur together and grouping individuals according to the characteristic pattern of their chronic illnesses. This approach, sometimes described as person-centered rather than disease-centered, allowed the team to ask whether the protective effect of exercise against mobility loss was homogeneous across these clinically distinct constellations of disease.

The technical rationale for such heterogeneity is compelling. Different disease clusters disable the body through different physiological pathways. Cardiometabolic patterns, typically combining type 2 diabetes, hypertension and obesity, limit mobility largely through vascular damage, impaired muscle perfusion and peripheral neuropathy, all of which erode the capacity for sustained aerobic effort. Osteoarticular patterns, dominated by osteoarthritis and chronic pain, restrict movement through mechanical limitation and pain-avoidance behavior that accelerates deconditioning. Cardiorespiratory and neuropsychiatric patterns act through reduced aerobic reserve, breathlessness and fatigue, and through the motivational deficits associated with depression. A walking-based intervention that increases daily physical activity might, in principle, counteract deconditioning in all of these groups, but the magnitude of the achievable gain could differ substantially depending on which bottleneck — vascular, mechanical, respiratory or psychological — dominates the individual patient’s trajectory.

The analysis confirmed that suspicion in a clinically meaningful way. The benefits of the multicomponent physical activity program on the risk of developing major mobility disability were not uniform across multimorbidity patterns. For some clusters of conditions, the intervention produced clear and robust protection: frail older adults whose chronic disease burden followed certain patterns experienced a significantly lower hazard of losing the ability to walk 400 meters when they exercised regularly compared with their counterparts receiving health education alone. For other patterns, the observed benefit was attenuated and statistically uncertain, suggesting that standard exercise prescriptions may need to be adapted — or supplemented with other treatments — to reach patients whose disabling pathway is driven by disease mechanisms that physical activity alone cannot fully offset. The precise estimates, hazard ratios and interaction terms reported in the article quantify this differential effect, providing effect-size benchmarks that guideline developers and trial designers can build upon.

Methodologically, the study is a careful exercise in post-hoc subgroup science, a field notorious for false positives. The authors handled the inherent risks by defining multimorbidity patterns using prespecified statistical procedures, applying clustering algorithms to baseline disease data, testing interactions between intervention assignment and pattern membership, and adjusting for the covariates that typically confound mobility outcomes, including age, sex, baseline physical performance, body mass index and gait speed. Sensitivity analyses examined whether the results were robust to alternative cluster definitions and to variations in the handling of missing data. Although the analysis was not powered a priori for pattern-specific comparisons — a limitation the authors acknowledge — the coherence of the findings across analytic choices lends credibility to the central conclusion: multimorbidity is not a monolith, and its internal structure matters for prevention.

The implications reach well beyond the walls of geriatric medicine. Health systems across Europe, North America and Asia are confronting a demographic transition in which the majority of people over sixty-five live with at least two chronic conditions. Current guidelines for these patients are typically assembled disease by disease — a cardiology recommendation, a diabetes recommendation, an orthopedic recommendation — with little attention to how the combination of conditions changes what prevention can achieve. The SPRINTT analysis provides an empirical basis for a different model, one in which the pattern of multimorbidity becomes a stratification variable in clinical decision-making. A physical activity prescription for a frail older patient with a cardiometabolic cluster may be among the most effective interventions available; for a patient whose mobility is limited by a different cluster, the same prescription may need reinforcement with pain management, nutritional support, depression treatment or assistive technology to translate into preserved walking ability.

The findings also intersect with a growing body of research on physical resilience — the capacity of an organism to resist and recover from health stressors. Frailty, understood as a state of diminished physiological reserve, has often been treated as a single construct measured with composite scores such as the frailty phenotype or the frailty index. The SPRINTT results suggest that the trajectory of frail older adults is better predicted by a vector than by a scalar: the direction of their disease burden, not merely its magnitude, determines how plastic their mobility remains. This resonates with mechanistic work on the biology of aging, in which distinct molecular hallmarks — chronic inflammation, mitochondrial dysfunction, cellular senescence, neuromuscular junction degeneration — are differentially engaged by different chronic diseases and may respond differently to exercise as a systemic intervention. Physical activity is one of the few therapies known to act simultaneously on most of these pathways, which helps explain why it remains effective, if unevenly so, across clinically diverse populations.

Questions inevitably remain. The trial population consisted of community-dwelling Europeans selected for physical frailty and sarcopenia, so the generalizability of the pattern-specific results to frailer institutionalized populations, to non-European cohorts or to younger adults with early multimorbidity has not been demonstrated. The clustering solution chosen by the investigators is one of several statistically defensible partitions of the disease space, and alternative algorithms might yield patterns with different boundaries. And although major mobility disability is a validated and consequential endpoint, future work should examine whether multimorbidity patterns also moderate the effects of exercise on other outcomes, including falls, hospitalization, cognitive decline and mortality. Longer follow-up, larger samples and replication in independent cohorts will be needed before pattern-stratified exercise prescriptions become standard clinical practice.

Even with those caveats, the study marks a turning point in how the prevention of disability in old age can be conceptualized. It moves the field away from the blunt arithmetic of disease counting and toward a nosology of combinations, in which the specific constellation of conditions a person carries is treated as clinically actionable information. It also delivers a pragmatic message of hope with nuance: exercise remains one of the most powerful tools available for keeping frail older adults on their feet, but its power is conditional, and understanding those conditions is the key to unlocking it for everyone. As populations age and multimorbidity becomes the norm rather than the exception, the lesson from SPRINTT is that precision geriatrics — matching preventive interventions to the pattern of disease, not just to its burden — is no longer an aspiration but an evidence-backed necessity.